News and Updates
Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
Update on the 2025 call topics for cluster 5
You may have noticed that call topics for 2025 are not yet available on the Funding & Tenders Portal. This is due to ongoing preparatory work, but even though updates are expected in the coming months, adoption will be the earliest in April 2025. To stay ahead, consider reading a draft version.
A bit on the process
A work programme is typically drafted in stages. It begins with setting priorities, after which topics are drafted in collaboration between the EC, expert groups and stakeholders. This initial phase is followed by consultations with Member States and advisory bodies. Drafts undergo subsequently several reviews and revisions before their final adoption. Once a work programme is adopted, the call topics are published on the Funding & Tenders Portal.
Timing for WP 2025
The procedure for consultation of the stakeholders runs until the end of this year, after which an Inter-Service Consultation will take place in Jan-Feb 2025. This will lead to a version that is expected to be adopted by the Programme Committee in March 2025, so that the Work Programme can finally be adopted in April 2025.
Start preparing
The best way to prepare is by reading the draft work programme. Even though there are not final documents, they do give a good indication on what to expect.
The easiest way forward it to download version from 29-04-24 on Science Business. More recent versions are available with the Programme Committee delegates. Stakeholders located in Flanders can turn to the Programme Committee delegates of the Department of Economy, Science and Innovation with questions regarding the Work Programme during this preparation phase. For Cluster 5, in Flanders, this is Lut Bollen.
Related News
|
2025-01-15
|
6 hours ago |
cut-off date for clean aviation pitch-athlon extended |
|
2025-01-07
|
1 week ago |
Survey on the driving urban transitions (DUT) partnership |
|
2024-12-16
|
4 weeks ago |
EIT urban mobility: open call for financial support to start-ups |
|
2024-12-04
|
1 month ago |
The Strategic Technologies for Europe Platform - the STEP funding dashboard with open... |
|
2024-11-05
|
2 months ago |
NCP Flanders team: Reshuffle of responsibilities of our NCP Advisors - Horizon Europe... |
|
2024-09-20
|
3 months ago |
Database on transnational and virtual access to research infrastructures for all scie... |
|
2024-09-19
|
3 months ago |
Become an expert to evaluate SSH aspects in the Cluster 5 calls |
|
2024-09-18
|
3 months ago |
Cluster 5 (D3&D4) calls are now open for submission |
myOVERVIEW
-
sign up for personalised information
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Latest News
1515 articles available search in articlesDigital, Industry & Space Semiconductors
Chips JU updated work programme
The Chips Joint Undertaking has published an update of its 2023-2027 Multiannual Work Programme, with significant updates to its strategic initiatives for 2025. The Chips JU manages calls for funding both under Horizon Europe and Digital Europe. An overview of the updates can be found on the Chips JU website, as is the work programme. read more
Testimonial
Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
